Skip to main content

Table 5 Treatment outcomes of fluoropyrimidines vs. gemcitabine

From: Gemcitabine-based versusfluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study

  F based G based P value
Number of patients 144 99 < 0.0001
   With P 83 94  
   Without P 61 5  
RR (%) 19.5 16.7 0.591
DCR (%) 58.9 52.8 0.372
PFS (months) 4.3 (95% CI, 3.3–5.3) 4.0 (95% CI, 2.9–5.1) 0.816
OS (months) 9.1 (95% CI, 7.1–11.1) 7.8 (95% CI, 6.5–9.2) 0.848
  1. F, fluoropyrimidines; G, gemcitabine; P, platinum; RR, response rate; DCR, disease control rate; PFS, progression free survival; CI, confidence interval; OS, overall survival